MarketPeel
Chief Development Officer
Wed, Aug 19, 2026
5d ago
sold $20.16k of RAPP
404 shares @ $49.90
Decreased holdings by -0.20%
6th largest trade (out of 12)
Planned (10b5-1)
These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on December 10, 2025.Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 47% above 200-day moving average
RAPPRapport Therapeutics, Inc.
HealthcareBiotechnology
1D0.00%
1W-0.37%
1M+18.58%
3M+21.48%
6M
1Y

Recent insider activity at RAPP

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback